J. D. Berman

761 total citations
10 papers, 625 citations indexed

About

J. D. Berman is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Rheumatology. According to data from OpenAlex, J. D. Berman has authored 10 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 5 papers in Epidemiology and 3 papers in Rheumatology. Recurrent topics in J. D. Berman's work include Research on Leishmaniasis Studies (9 papers), Trypanosoma species research and implications (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). J. D. Berman is often cited by papers focused on Research on Leishmaniasis Studies (9 papers), Trypanosoma species research and implications (5 papers) and Eosinophilic Disorders and Syndromes (3 papers). J. D. Berman collaborates with scholars based in United States, Panama and Germany. J. D. Berman's co-authors include Thomas R. Navin, Byron Arana, Henry W. Murray, Samuel D. Wright, W. Ripley Ballou, J. Bruce McClain, G. Dennis Shanks, William D. Johnson, F. Rosenkaimer and Carl M. Johnson and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

J. D. Berman

10 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. D. Berman United States	10	554	354	89	76	63	10	625
C.N. Chunge Kenya	9	400 0.7×	247 0.7×	85 1.0×	59 0.8×	20 0.3×	16	478
Gianfranco Tulliano Peru	7	540 1.0×	318 0.9×	98 1.1×	52 0.7×	59 0.9×	9	580
Julia Toledo Bolivia	13	1.0k 1.9×	484 1.4×	131 1.5×	134 1.8×	79 1.3×	13	1.1k
Sashi Sharma Nepal	6	624 1.1×	402 1.1×	125 1.4×	96 1.3×	53 0.8×	13	700
O. A. Martins‐Filho Brazil	12	431 0.8×	361 1.0×	130 1.5×	44 0.6×	99 1.6×	16	519
M K Makharia India	7	450 0.8×	269 0.8×	100 1.1×	67 0.9×	29 0.5×	7	494
George Kirigi Kenya	12	442 0.8×	277 0.8×	101 1.1×	95 1.3×	27 0.4×	25	473
M Shiroma Brazil	12	227 0.4×	269 0.8×	87 1.0×	26 0.3×	36 0.6×	35	443
Eric Henrique Roma Brazil	10	340 0.6×	195 0.6×	88 1.0×	35 0.5×	151 2.4×	16	474
F. Badaró Brazil	6	329 0.6×	222 0.6×	89 1.0×	36 0.5×	100 1.6×	9	438

Countries citing papers authored by J. D. Berman

Since Specialization

Citations

This map shows the geographic impact of J. D. Berman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. D. Berman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. D. Berman more than expected).

Fields of papers citing papers by J. D. Berman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. D. Berman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. D. Berman. The network helps show where J. D. Berman may publish in the future.

Co-authorship network of co-authors of J. D. Berman

This figure shows the co-authorship network connecting the top 25 collaborators of J. D. Berman. A scholar is included among the top collaborators of J. D. Berman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. D. Berman. J. D. Berman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Arana, Byron, et al.. (1994). Efficacy of a Short Course (10 Days) of High-Dose Meglumine Antimonate With or Without Interferon- in Treating Cutaneous Leishmaniasis in Guatemala. Clinical Infectious Diseases. 18(3). 381–384. 44 indexed citations

2.

Navin, Thomas R., et al.. (1992). Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala. The Journal of Infectious Diseases. 165(3). 528–534. 242 indexed citations

3.

Saenz, Rolando E., et al.. (1991). Efficacy and Toxicity of Pentostam against Panamanian Mucosal Leishmaniasis. American Journal of Tropical Medicine and Hygiene. 44(4). 394–398. 30 indexed citations

4.

Murray, Henry W., J. D. Berman, & Samuel D. Wright. (1988). Immunochemotherapy for Intracellular Leishmania donovani Infection: Interferon Plus Pentavalent Antimony. The Journal of Infectious Diseases. 157(5). 973–978. 121 indexed citations

5.

Berman, J. D.. (1988). Inhibition of Leishmanial Protein Kinase by Antileishmanial Drugs. American Journal of Tropical Medicine and Hygiene. 38(2). 298–303. 9 indexed citations

6.

Ballou, W. Ripley, et al.. (1987). SAFETY AND EFFICACY OF HIGH-DOSE SODIUM STIBOGLUCONATE THERAPY OF AMERICAN CUTANEOUS LEISHMANIASIS. The Lancet. 330(8549). 13–16. 84 indexed citations

7.

Berman, J. D., et al.. (1986). Activity of Pentamidine-Containing Human Red Cell Ghosts against Visceral Leishmaniasis in the Hamster. American Journal of Tropical Medicine and Hygiene. 35(2). 297–302. 11 indexed citations

8.

Berman, J. D., et al.. (1983). Activity of Oral Drugs against Leishmania Tropica in Human Macrophages in Vitro. American Journal of Tropical Medicine and Hygiene. 32(5). 947–951. 35 indexed citations

9.

Berman, J. D., et al.. (1983). Activity of 8-Aminoquinolines against Leishmania Tropica within Human Macrophages in Vitro. American Journal of Tropical Medicine and Hygiene. 32(4). 753–759. 27 indexed citations

10.

Berman, J. D. & William D. Johnson. (1978). Monocyte function in human neonates. Infection and Immunity. 19(3). 898–902. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact